CHU Gabriel-Montpied

4 trials 2 recruiting Academic / non-commercial

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

1 Countries active

12 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 1 Phase IV: 1

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

ALLOGENEIC FAECAL MICROBIOTA 1 CISATRACURIUM BESILATE 1 DEXMEDETOMIDINE 1 L-LYSINE ACETATE, L-TRYPTOPHAN, L-HISTIDINE, LYSINE ACETATE, L-THREONINE, L-TYROSINE, KETO-ISOLEUCINE CALCIUM, KETO-LEUCINE CALCIUM, KETO-VALINE CALCIUM, HYDROXI-METHIONINE CALCIUM, ALPHA-KETOPHENYLALANINE CALCIUM 1 MIDAZOLAM 1 PROPOFOL 1 SEVOFLURANE 1

All trials

4 total

Ketoanalogue Supplementation for Muscle Protection in chronic kidney disease (stade 4 and 5) Patients with Moderately Low Protein Diet Recruiting

2024-516764-29-00 Phase III 1 country L-LYSINE ACETATE, L-TRYPTOPHAN, L-HISTIDINE, LYSINE ACETATE, L-THREONINE, L-TYRO…
Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic… Recruiting

2024-512969-14-01 Phase II 1 country ALLOGENEIC FAECAL MICROBIOTA
Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distre… Ended

2024-517670-15-00 Phase III 1 country CISATRACURIUM BESILATE; DEXMEDETOMIDINE; MIDAZOLAM; PROPOFOL; SEVOFLURANE
Balloon + Oxytocin versus Oral Misoprostol to Induce labor in case of premature rupture of membranes (PROM) at term in nulliparous Ended

2022-501142-30-00 Phase IV 1 country

Showing 1–4 of 4 trials

← All sponsors A–Z